• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

商业化和基因数据共享安排对公众信任及参与生物样本库研究意愿的影响。

The impact of commercialisation and genetic data sharing arrangements on public trust and the intention to participate in biobank research.

作者信息

Critchley Christine, Nicol Dianne, Otlowski Margaret

机构信息

Department of Psychological Sciences, Faculty of Health, Arts and Design, Swinburne University of Technology, Hawthorn, Vic., Australia.

出版信息

Public Health Genomics. 2015;18(3):160-72. doi: 10.1159/000375441. Epub 2015 Mar 13.

DOI:10.1159/000375441
PMID:25790760
Abstract

OBJECTIVES

The necessity for biobanks to share their resources with third parties poses potential risks to public trust and the intention to participate in genetic research. We explore the effects of data sharing and the type of third-party access (public vs. private) on public trust and, in turn, the intention to participate in biobank research.

METHODS

An experimental design was used to assess a national sample of 1,701 Australians via a computer-assisted telephone interview.

RESULTS

The results revealed that trust and the intention to participate significantly decreased in relation to private compared to public biobanks, and when access to third-party researchers was allowed compared to when it was not. Somewhat surprisingly, no differences were found in relation to the third party being international compared to Australian, but trust and the intention to participate were significantly eroded when private third parties were allowed access. Those with a university education were particularly distrustful of private biobanks and biobanks that allowed access, while those who were more aware of genetic databases appeared more confident with biobanks sharing with private-sector third parties.

CONCLUSION

The pattern of results suggests that public awareness of the need for biobanks to share their resources widely needs to be increased to maintain public trust and support.

摘要

目的

生物样本库与第三方共享资源的必要性给公众信任以及参与基因研究的意愿带来了潜在风险。我们探讨了数据共享以及第三方访问类型(公共访问与私人访问)对公众信任的影响,进而探讨其对参与生物样本库研究意愿的影响。

方法

采用实验设计,通过计算机辅助电话访谈对1701名澳大利亚人组成的全国样本进行评估。

结果

结果显示,与公共生物样本库相比,私人生物样本库的信任度和参与意愿显著降低;与不允许第三方研究人员访问相比,允许访问时信任度和参与意愿显著降低。 somewhat令人惊讶的是,与澳大利亚第三方相比,国际第三方在这方面没有发现差异,但允许私人第三方访问时,信任度和参与意愿会显著受到侵蚀。受过大学教育的人对私人生物样本库和允许访问的生物样本库尤其不信任,而那些对基因数据库了解更多的人似乎对生物样本库与私营部门第三方共享资源更有信心。

结论

结果模式表明,需要提高公众对生物样本库广泛共享资源必要性的认识,以维持公众信任和支持。

相似文献

1
The impact of commercialisation and genetic data sharing arrangements on public trust and the intention to participate in biobank research.商业化和基因数据共享安排对公众信任及参与生物样本库研究意愿的影响。
Public Health Genomics. 2015;18(3):160-72. doi: 10.1159/000375441. Epub 2015 Mar 13.
2
The Skeleton in the Closet: Faults and Strengths of Public Versus Private Genetic Biobanks.壁橱里的骷髅:公共与私人遗传生物银行的优缺点。
Biomolecules. 2020 Sep 3;10(9):1273. doi: 10.3390/biom10091273.
3
Predicting intention to biobank: a national survey.预测生物库意向:一项全国性调查。
Eur J Public Health. 2012 Feb;22(1):139-44. doi: 10.1093/eurpub/ckq136. Epub 2010 Oct 5.
4
Transparency of Biobank Access in Canada: An Assessment of Industry Access and the Availability of Information on Access Policies and Resulting Research.加拿大生物样本库访问的透明度:对行业访问以及访问政策和相关研究信息可用性的评估
J Empir Res Hum Res Ethics. 2017 Dec;12(5):310-325. doi: 10.1177/1556264617723137. Epub 2017 Aug 17.
5
Identifying the nature and extent of public and donor concern about the commercialisation of biobanks for genomic research.确定公众和捐赠者对基因组研究用生物银行商业化的性质和程度的关注。
Eur J Hum Genet. 2021 Mar;29(3):503-511. doi: 10.1038/s41431-020-00746-0. Epub 2021 Jan 21.
6
Public Attitudes toward Consent and Data Sharing in Biobank Research: A Large Multi-site Experimental Survey in the US.公众对生物样本库研究中的知情同意和数据共享的态度:美国一项大型多地点实验性调查
Am J Hum Genet. 2017 Mar 2;100(3):414-427. doi: 10.1016/j.ajhg.2017.01.021. Epub 2017 Feb 9.
7
Commercial biobanks and genetic research: ethical and legal issues.商业生物样本库与基因研究:伦理和法律问题
Am J Pharmacogenomics. 2003;3(3):203-15. doi: 10.2165/00129785-200303030-00006.
8
Parents' attitudes toward consent and data sharing in biobanks: A multisite experimental survey.父母对生物样本库中同意和数据共享的态度:一项多地点实验性调查。
AJOB Empir Bioeth. 2018 Jul-Sep;9(3):128-142. doi: 10.1080/23294515.2018.1505783. Epub 2018 Sep 21.
9
Identifying public expectations of genetic biobanks.识别公众对遗传生物库的期望。
Public Underst Sci. 2017 Aug;26(6):671-687. doi: 10.1177/0963662515623925. Epub 2016 Jan 14.
10
[Ethical problems presented by collections of biological material and associated data: "biobanks", "bioethics"].生物材料及相关数据收集所带来的伦理问题:“生物样本库”,“生物伦理学”
J Int Bioethique. 2005 Sep-Dec;16(3-4):141-51.

引用本文的文献

1
Opportunities for a national genomic data governance framework in Australia: a systematic review.澳大利亚国家基因组数据治理框架的机遇:一项系统综述
BMC Med Ethics. 2025 Aug 14;26(1):111. doi: 10.1186/s12910-025-01273-7.
2
Commercialisation fears and preferred forms of governance: a mixed methods investigation to identify a trusted Australian genomics repository.商业化担忧与偏好的治理形式:一项混合方法调查,旨在确定一个受信任的澳大利亚基因组学知识库。
Front Public Health. 2024 Dec 13;12:1508261. doi: 10.3389/fpubh.2024.1508261. eCollection 2024.
3
Workplace genetic testing: which employees are likely to participate, what are their concerns with employer sponsorship, and which design features could reduce barriers and increase participation?
职场基因检测:哪些员工可能会参与,他们对雇主赞助有哪些担忧,以及哪些设计特点可以减少障碍并提高参与度?
Front Genet. 2024 Dec 4;15:1496900. doi: 10.3389/fgene.2024.1496900. eCollection 2024.
4
The effect of scientific conspiracy theories on scepticism towards biotechnologies.科学阴谋论对生物技术怀疑态度的影响。
Public Underst Sci. 2025 Jul;34(5):646-664. doi: 10.1177/09636625241300896. Epub 2024 Dec 4.
5
Towards a trusted genomics repository: Identifying commercialisation fears and preferred forms of governance across segments of the community.迈向可信赖的基因组学知识库:识别商业化担忧以及社区各阶层偏好的治理形式。
Public Underst Sci. 2025 Apr;34(3):325-343. doi: 10.1177/09636625241286369. Epub 2024 Oct 11.
6
Genetic tests as the strongest motivator of cooperation between participants and biobanks-Findings from cross-sectional study.基因检测作为参与者与生物样本库合作的最强有力推动因素——横断面研究结果
Front Genet. 2024 May 17;15:1321690. doi: 10.3389/fgene.2024.1321690. eCollection 2024.
7
Do biobanks need pharmacists? Support of pharmacy students to biobanking of human biological material for pharmaceutical research and development.生物样本库需要药剂师吗?药学专业学生对用于药物研发的人类生物样本生物样本库的支持。
Front Pharmacol. 2024 May 10;15:1406866. doi: 10.3389/fphar.2024.1406866. eCollection 2024.
8
A systematic literature review of the 'commercialisation effect' on public attitudes towards biobank and genomic data repositories.一项关于“商业化效应”对公众对生物银行和基因组数据库的态度影响的系统文献综述。
Public Underst Sci. 2024 Jul;33(5):548-567. doi: 10.1177/09636625241230864. Epub 2024 Feb 22.
9
Public attitudes towards genomic data sharing: results from a provincial online survey in Canada.公众对基因组数据共享的态度:加拿大某省在线调查结果
BMC Med Ethics. 2023 Oct 7;24(1):81. doi: 10.1186/s12910-023-00967-0.
10
An agenda-setting paper on data sharing platforms: euCanSHare workshop.一份关于数据共享平台的议程设置文件:欧盟癌症数据共享研讨会
Open Res Eur. 2021 Nov 23;1:80. doi: 10.12688/openreseurope.13860.2. eCollection 2021.